FDA Will Now Review Moderna’s Flu Vaccine

Moderna said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine after it had initially refused to do so, citing flaws in the trial design.The FDA has accepted Moderna’s revised approach seeking full approval for the shot for adults…

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.